26 results on '"Nordestgaard, Børge G"'
Search Results
2. SGLT2-inhibition increases total, LDL, and HDL cholesterol and lowers triglycerides: Meta-analyses of 60 randomized trials, overall and by dose, ethnicity, and drug type
3. Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial
4. Elevated plasma apolipoprotein E levels in people living with HIV: Associations with biomarkers and HIV-specific risk factors
5. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis
6. APOE and vascular disease: Sequencing and genotyping in general population cohorts
7. Triglyceride content increases while cholesterol content decreases in HDL and LDL+IDL fractions following normal meals: The Copenhagen General Population Study of 25,656 individuals
8. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals
9. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
10. Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality
11. Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms
12. Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: The Copenhagen General Population Study
13. Self-reported and genetically predicted coffee consumption and smoking in dementia: A Mendelian randomization study
14. The importance of nonobstructive plaque characteristics in symptomatic and asymptomatic coronary artery disease.
15. How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)?
16. Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
17. Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.
18. Corrigendum to Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association [Journal of Clinical Lipidology Volume 13, Issue 3, May–June 2019, Pages 374-392].
19. Elevated Remnant Cholesterol Reclassifies Risk of Ischemic Heart Disease and Myocardial Infarction.
20. Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review.
21. Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events.
22. Elevated LDL Triglycerides and Atherosclerotic Risk.
23. Physical activity in leisure time and at work and risk of dementia: A prospective cohort study of 117,616 individuals.
24. Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score.
25. Early Coronary Atherosclerosis in Women With Previous Preeclampsia.
26. Lipoprotein(a) and Body Mass Compound the Risk of Calcific Aortic Valve Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.